Status:

RECRUITING

Changes in Ciprofol Dosage in Insomnia Patients Undergoing Digestive Endoscopy

Lead Sponsor:

Beijing Tiantan Hospital

Collaborating Sponsors:

Daxing Teaching Hospital, Capital Medical University

Hebei Medical University Third Hospital

Conditions:

Insomnia

Digestive Endoscopy

Eligibility:

All Genders

18-64 years

Brief Summary

To compare the dosage requirement of ciprofol during digestive endoscopy between patients with insomnia and those with normal sleep pattern.

Detailed Description

The investigators aim to investigate whether ciprofol dosage requirement is increased in patients with insomnia undergoing digestive endoscopy compared with normal sleep patterns.

Eligibility Criteria

Inclusion

  • Patients with insomnia:
  • Age of 18 - 64 years;
  • ASA physical status of I - II;
  • BMI of 15 - 30;
  • Scheduled for digestive endoscopy under intravenous anesthesia;
  • Positive screening results according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for insomnia disorder;
  • 8-item Sleep Condition Indicator (SCI; score 0-4; range 0-32, higher score means better sleep) scored 16 or less;
  • Patients with normal sleep:
  • Age of 18 - 64 years;
  • ASA physical status of I - II;
  • BMI of 15 - 30;
  • Scheduled for digestive endoscopy under intravenous anesthesia;
  • No history or evidence of insomnia.

Exclusion

  • Associated with any neurological disease;
  • Daily alcohol consumption;
  • Any contraindication to intravenous anesthetic drug, such as hypotension or shock;
  • History of allergy to any drug used in the study;
  • Pregnancy or breastfeeding;
  • Patients with sleep apnea syndrome;
  • acute upper respiratory infection;
  • Patients with psychological diseases who report suicidal thoughts;
  • Patients who need to work or take care of children/elderly people frequently at night.

Key Trial Info

Start Date :

March 24 2025

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 31 2027

Estimated Enrollment :

840 Patients enrolled

Trial Details

Trial ID

NCT06897007

Start Date

March 24 2025

End Date

March 31 2027

Last Update

September 10 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beijing Tiantan Hospital

Beijing, Beijing Municipality, China, 100070